Risk Management
Drugs and Devices
Welcome to OMIC’s Drugs and Devices risk management resource library, a comprehensive collection of loss prevention and patient safety resources for ophthalmic practices.
Our resources for Drugs and Devices include model consent forms, risk management articles, closed claim studies, and recommendation and procedure guides.
Articles (15)
Coumadin and Ocular Anesthesia
Are Patients Who Chose Premium IOLs a Malpractice Risk?
Message from the Chairman discusses FDA and Allergan’s Trivaris drug
When FDA Leaves Doctors to Their Own Devices
Medication Errors Result in Costly Claims for Ophthalmologists
Discuss Potential Side Effects of Eye Drops
CO2 Laser Skin Resurfacing: Watch Out for Marketing Liability
Assuring Safe Passage Through the Healthcare System
Delay in Diagnosis Key to Endophthalmitis Claims
Medicolegal Implications of Using Off-Label Drugs and Devices
Compounded Products: Use, Regulation, and Risk
Allergan Voluntary Recall of OZURDEX
2019 January Alert: OZURDEX Recall
Case Studies (10)
Defense Verdict in Alleged Negligent Placement of Crystalens
Lack of Informed Consent for Use of Research Drug
Medication Error Underlines Importance of Informed Consent
Cosmetic Treatment by Technician Results in Fine and Suspended License for Medical Director
Alleged Negligent Placement of Crystalens
Complicated Course of Chronic Iritis
Codefendant Ophthalmologist Testifies Against OMIC Insured at Trial
Failure to Diagnose an Eye Infection
Injection of Anecortave Acetate into Globe during ARMD Risk Reduction Trial
Consent Forms (2)
Coverage Issues (2)
Medicolegal Implications of Using Off-Label Drugs and Devices
Patient Issues (4)
Warn Patients about Side Effects of Dilating Drops
Contact Lens Prescription Copy Request (Sample Letter)
Practice Issues (15)
Coumadin and Ocular Anesthesia
Are Patients Who Chose Premium IOLs a Malpractice Risk?
Endophthalmitis/TASS Investigation Protocol
Message from the Chairman –Cost of Avastin
Will FDA Regulations Preempt Personal Injury Suits?
Safe Medical Devices Act: Reporting Requirements and Risk Management Concerns
Dilating Drops: Patient Safety and Liability Risks
CO2 Laser Skin Resurfacing: Watch Out for Marketing Liability
Cosmetic Treatment by Technician Results in Fine and Suspended License for Medical Director
Coverage for Use of Premium IOLs
Assuring Safe Passage Through the Healthcare System
Responding to “Dear Healthcare Provider” Letters
Recommendations (8)
Dilating Drops: Patient Safety and Liability Risks
AAO prescribing recommendations for Latisse
Checklist for Risk Analysis of Unapproved Devices
